🏛️ Verified NIH Record • Updated 2026-02-11
Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial (NCT06212323)
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: University of Utah
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to define the natural history of high-risk smoldering myeloma in a modern cohort of patients undergoing close standard of care follow-up with diffusion weighted whole body magnetic resonance imaging.
Who can join: Review the eligibility criteria below.
Location: Huntsman Cancer Institute at the University of Utah — Salt Lake City, Utah
Age range: 18 Years
🧪 Interventions in This Study
- Patients with smoldering myeloma undergoing active surveillance with diffusion weighted whole body MRI. (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Huntsman Cancer Institute at the University of Utah — Salt Lake City, Utah
📞 Contact the Study Coordinator
Phone: (801) 585-0255
Email: Sharmilee.Nuli@hci.utah.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Smoldering Multiple Myeloma
- Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant — Tampa, Florida
- A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM — Boston, Massachusetts
- Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma — Rochester, New York
- Screening for AL Amyloidosis in Smoldering Multiple Myeloma — Birmingham, Alabama
Explore by condition: All Smoldering Multiple Myeloma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.